Zydus Wellness Analyst Review May 2026
- May 21, 2026
- Posted by: Kunal Singla
- Category: News
This Zydus Wellness analyst review for May 2026 covers the key data investors need for ZYDUSWELL at its current price of Rs 490.10. Zydus Wellness (NSE: ZYDUSWELL) is a leading health and wellness FMCG company with a market capitalisation of approximately Rs 9,500 crore, known for Sugar Free, Complan, Glucon-D, and Everyuth brands. The analyst consensus target of Rs 1,800 implies meaningful upside, and this Zydus Wellness analyst review examines technical levels, business performance, valuation, and key risks for ZYDUSWELL through FY27.
Click Here – Get Free Investment Predictions
Zydus Wellness Company Snapshot May 2026
Zydus Wellness’ brands address preventive health (Sugar Free, Glucon-D), nutrition (Complan), and personal care (Everyuth). The health and wellness consumer trend in India and premiumisation of nutrition products are structural tailwinds. The table below summarises the key data referenced in this Zydus Wellness analyst review.
| Parameter | Value |
|---|---|
| NSE Ticker | ZYDUSWELL |
| Sector | FMCG – Healthcare and Nutrition |
| CMP (May 2026) | Rs 490.10 |
| 52 Week High | Rs 552.40 |
| 52 Week Low | Rs 358.54 |
| Market Cap | Rs 9,500 Crore |
| Trailing P/E | 38x |
| Analyst Consensus Target | Rs 1,800 |
| Bull Case Target | Rs 2,200 |
| Bear Case Target | Rs 1,200 |
Analyst Insight in This Zydus Wellness Analyst Review
Associate Director Kunal Singla suggests watching Zydus Wellness closely in May 2026. At Rs 490.10, Kunal Singla flags FMCG – Healthcare and Nutrition sector dynamics as the primary driver for ZYDUSWELL’s near-term price action. He notes support in the Rs 366 to Rs 466 zone and flags any sustained close above Rs 520 as a positive signal. Kunal Singla’s perspective adds professional analysis to this Zydus Wellness analyst review and is not a buy recommendation.
Technical Analysis in This Zydus Wellness Analyst Review
At Rs 490.10, ZYDUSWELL is trading within its 52-week band of Rs 358.54 to Rs 552.40. The current position relative to the 52-week high and low is the first layer of technical context for any entry or exit decision. Momentum indicators including the 14-day RSI, MACD crossover, and volume trends are useful secondary signals to monitor alongside the Nifty 50 direction.
Near-term support is identified in the Rs 366 to Rs 466 band while resistance is seen in the Rs 520 to Rs 1145 zone. A sustained move above Rs 520 could open the path toward the analyst consensus target of Rs 1,800 as identified in this Zydus Wellness analyst review.
Screen the best stocks on the Univest Screener.
Key Support and Resistance Levels
- Support Zone: Rs 366 to Rs 466 – investors tracking this Zydus Wellness analyst review should watch for stabilisation or a bounce in this range as a potential accumulation signal for ZYDUSWELL.
- Resistance Zone: Rs 520 to Rs 1145 – a sustained close above Rs 520 would be a positive breakout signal worth flagging in this Zydus Wellness analyst review.
- Medium-Term Target: The analyst consensus of Rs 1,800 represents the base-case upside scenario in this Zydus Wellness analyst review.
Business Segment Analysis
Sugar Substitutes (Sugar Free – Market Leader)
This is the primary revenue and margin driver for Zydus Wellness, directly supporting the earnings trajectory toward the consensus target of Rs 1,800.
Nutrition and Health Drinks (Complan, Glucon-D)
This segment adds scale and diversification to Zydus Wellness’s business model and is a meaningful EPS contributor through FY27 and FY28.
Personal Care (Everyuth Scrubs and Face Wash)
This represents the medium-term growth frontier for Zydus Wellness and a key re-rating catalyst for the stock over the next 12 to 24 months.
Valuation in This Zydus Wellness Analyst Review
At Rs 490.10, Zydus Wellness trades at a trailing P/E of 38x. This Zydus Wellness analyst review presents three scenarios: a bull case of Rs 2,200 on strong earnings delivery, a base case of Rs 1,800 at analyst consensus, and a bear case of Rs 1,200 if macro headwinds persist. Q1 FY27 results will be the first key checkpoint for this Zydus Wellness analyst review.
| Scenario | Target Price | Key Condition |
|---|---|---|
| Bull Case | Rs 2,200 | Strong earnings delivery and sector re-rating |
| Base Case (Consensus) | Rs 1,800 | Moderate growth, analyst consensus estimate |
| Bear Case | Rs 1,200 | Earnings miss or macro headwinds |
Trade Outlook for Zydus Wellness
Based on the technical and fundamental analysis in this Zydus Wellness analyst review, investors might watch ZYDUSWELL near the support zone of Rs 366 to Rs 466 for potential opportunities. A flag above Rs 520 could suggest improving momentum toward Rs 1,800. This article uses watch-and-flag language only and does not constitute a trade recommendation.
Key Risks for Zydus Wellness in FY27
A well-rounded Zydus Wellness analyst review must assess downside risks. Key risks for Zydus Wellness include a macro slowdown affecting FMCG – Healthcare and Nutrition sector demand, input cost or regulatory headwinds compressing margins, continued FII selling from Indian equities, and earnings estimate downgrades if Q1 FY27 guidance disappoints. Market conditions may change rapidly. This analysis is not financial advice; investors should perform their own due diligence before investing in ZYDUSWELL.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Conclusion: Zydus Wellness Analyst Review Verdict for 2026
This Zydus Wellness analyst review concludes that at Rs 490.10, ZYDUSWELL offers a defined risk-reward with a consensus target of Rs 1,800. The 52-week range of Rs 358.54 to Rs 552.40 provides context on the current entry point. Use this Zydus Wellness analyst review as a research starting point and consult a SEBI-registered financial advisor before making any investment decisions on ZYDUSWELL.
Frequently Asked Questions: Zydus Wellness Analyst Review 2026
What is the analyst target for Zydus Wellness in 2026?
The analyst consensus target is Rs 1,800, with a bull case of Rs 2,200 and a bear case of Rs 1,200. This Zydus Wellness analyst review recommends monitoring Q1 FY27 earnings for confirmation.
Is Zydus Wellness a good investment at Rs 490.10?
At Rs 490.10 with a P/E of 38x and a consensus target of Rs 1,800, this Zydus Wellness analyst review is constructive for medium to long-term investors in the FMCG – Healthcare and Nutrition sector. Always consult a SEBI-registered advisor before investing.
What is Zydus Wellness’s 52-week high and low?
The 52-week high is Rs 552.40 and the 52-week low is Rs 358.54. At Rs 490.10, ZYDUSWELL is positioned within this range as noted in this Zydus Wellness analyst review.
What are the key risks for Zydus Wellness?
Key risks include macro slowdown, input cost pressures, FII selling, and regulatory changes in the FMCG – Healthcare and Nutrition sector as assessed in this Zydus Wellness analyst review.
Where can I track live data for Zydus Wellness?
Track Zydus Wellness’s live price and analyst targets on the Univest Screener alongside professional financial advice to complement this Zydus Wellness analyst review.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.
